These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2984793)

  • 21. Prevalence of antibodies to human T-cell leukemia virus.
    Opperman JC; Rubin DM; Glocer J; Swanevelder C; Odendaal M; Prozesky OW
    S Afr Med J; 1984 Jul; 66(3):86. PubMed ID: 6330916
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody cross-reactivity of alphaherpesviruses as mirrored in naturally infected primates.
    Katz D; Shi W; Krug PW; Henkel R; McClure H; Hilliard JK
    Arch Virol; 2002 May; 147(5):929-41. PubMed ID: 12021865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries.
    de-Thé G; Gessain A; Gazzolo L; Robert-Guroff M; Najberg G; Calender A; Peti M; Brubaker G; Bensliman A; Fabry F
    Cancer Res; 1985 Sep; 45(9 Suppl):4633s-4636s. PubMed ID: 2990698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in Israel.
    Ben-Ishai Z; Haas M; Triglia D; Lee V; Nahmias J; Bar-Shany S; Jensen FC
    Nature; 1985 Jun 20-26; 315(6021):665-6. PubMed ID: 2989699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa.
    Biggar RJ; Johnson BK; Oster C; Sarin PS; Ocheng D; Tukei P; Nsanze H; Alexander S; Bodner AJ; Siongok TA
    Int J Cancer; 1985 Jun; 35(6):763-7. PubMed ID: 2989191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of assays for antibody to HTLVI.
    White PM
    J Clin Pathol; 1988 Jun; 41(6):700-2. PubMed ID: 2838531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.
    Kobayashi S; Yoshida T; Hiroshige Y; Matsui T; Yamamoto N
    J Clin Microbiol; 1988 Feb; 26(2):308-12. PubMed ID: 2893807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing antibodies to simian papovavirus SA12 in Old World primates in laboratory colonies: high prevalence in baboons.
    Braun L; Kalter SS; Yakovleva LA; Kaschula VR; Shah KV
    J Med Primatol; 1980; 9(4):240-6. PubMed ID: 6252324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
    Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
    J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study.
    van der Ryst E; Joubert G; Smith MS; Terblanche M; Mollentze F; Pretorius AM
    Cent Afr J Med; 1996 Mar; 42(3):65-8. PubMed ID: 8653770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenicity of human T-cell leukemia virus-associated gp52: greater response in leukemia patients compared to healthy donors exposed to the virus.
    Robert-Guroff M; Clark JW
    Cancer Res; 1985 Jul; 45(7):3374-7. PubMed ID: 2988770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-I-reactive antibody in the northern and eastern Transvaal.
    Botha MC; Jones M; de Klerk WA; Yamamoto N; Kobayashi S
    S Afr Med J; 1985 May; 67(18):707. PubMed ID: 2986301
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies to human adult T cell leukaemia virus type I associated antigens in Swedish leukaemia patients and blood donors.
    Blomberg J; Fäldt R
    Br J Haematol; 1985 Jul; 60(3):555-7. PubMed ID: 2990523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of HTLV-I antibodies in Africans.
    Weiss RA; Cheingsong-Popov R; Clayden S; Pegram S; Tedder RS; Barzilai A; Rubenstein E
    Nature; 1986 Feb 27-Mar 5; 319(6056):794-5. PubMed ID: 3005874
    [No Abstract]   [Full Text] [Related]  

  • 40. Natural antibodies to simian type-C viruses and human retrovirus HTLV in patients with lymphoid malignancies.
    Tóth FD; Szabó B; Váczi L; Kiss A; Kovács I; Rák K; Kiss C; Gallo RC
    Acta Microbiol Hung; 1984; 31(4):387-92. PubMed ID: 6100223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.